Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**EuBone** is a proprietary oral botanical blend formulated from extracts of *Cuscuta chinensis*, *Drynaria fortunei*, and *Eucommia ulmoides*. It is being clinically evaluated in postmenopausal women with osteopenia or postmenopausal osteoporosis for its potential to slow bone loss and support bone health. EuBone has no publicly established single molecular target or validated target-specific mechanism of action; its proposed benefit is based on the combined activity of its herbal constituents. ([chenland.com](https://www.chenland.com/pages/bone-support))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EuBone (Qingdao Chenlan Pharmaceutical).